Actualités

Even if a megamerger fails to materialize, investors stand to benefit from a wave of M&A activity in the biopharma sector.

Merck slashed its profit outlook for the year due to charges tied to its acquisition of cancer biotech company Terns Pharmaceuticals.

Chinese robot maker Unitree Technology is expected to be valued ‌at more than 50 billion yuan ($7.4 billion) after its planned ‌Shanghai IPO, according to a report by Citic Securities, which is sponsoring the initial ​public offering. Citic Securities expected the Hangzhou-based company to be worth 50.6 billion to 55.9 billion yuan six to 12 months after listing later this month. The valuation report, distributed to investors and seen by ‌Reuters, is largely seen ⁠as guidance ahead of Wednesday's IPO price enquiry.

SpaceX (NASDAQ:SPCX) is due to publish its quarterly results after the close of trading on Tuesday, marking the company’s first earnings report since its highly anticipated stock market debut. The release is expected to provide investors with a clearer picture of whether the company’s financial performance supports the ambitious growth expectations that accompanied its listing, particularly as it continues to invest heavily in artificial intelligence and space technologies.

Robinhood (NASDAQ:HOOD) is seeking to raise up to $200 million through the U. S.

The transaction was first announced in March, when Mastercard signed an agreement to acquire BVNK for up to $1.8bn.

Big drug companies have been buying scrappy biotechs to expand their pipelines, but the potential megamerger between AstraZeneca and Bristol Myers Squibb could flip that script.

Elon Musk’s net worth continued to plunge this week as shares of his two flagship companies, Tesla and SpaceX, retreated amid swirling merger speculation, with traders also positioning ahead of SpaceX’s upcoming earnings report. Elon Musk Net Worth is Down...

Mastercard finally closed its acquisition of London-based stablecoin infrastructure provider BVNK on August 3, 2026. If you have ever wondered what happens when the plumbing of global finance decides to move inside the house, this is your answer. It is not just another corporate press release about a strategic partnership; it is the moment the […]

Another SMR stock is expected to make its public debut.

Investors questioned whether combining AstraZeneca with Bristol Myers would strengthen growth enough to justify the financial and regulatory risks.

The Ark Invest founder is betting big on SpaceX.

Suze Orman walked through a real SpaceX IPO trade that turned $10,000 into roughly $5,600 in seven weeks, and her lesson has nothing to do with rockets or Elon Musk.

The Bithumb crypto exchange is preparing for a 2028 initial public offering (IPO) after reorganizing its business and setting out a two-year program to strengthen accounting, compliance and risk controls. South Korea’s largest cryptocurrency exchange said it expects to complete internal-control ...

Apple's Latest Acquisition Signals a Bigger Push Into AI and Advanced Chips

The UK drugmaker is reportedly talking to Bristol Myers Squibb about a nearly $400 billion tie-up, but investors are struggling to diagnose the logic.

The fund holds 80 private companies and focuses on Y Combinator startups, with shares expected to list on the NYSE on August 13

Rocket Lab is rapidly transforming from a launch company into a diversified space business, positioning it for profits and strong free cash flow as early as next year.

As stocks like Eli Lilly, Twilio, Hinge Health and more move ahead of earnings report, pay attention to these chart lines.

The FTSE 100 index closed down 10.35 points, 0.1%, at 10,857.70.

One of the largest global pharma companies would be created if a deal were to materialise.

BMY surged roughly 6% in premarket trading on the news before fading; the stock is now trading near flat. The asymmetric price reaction captures the market's immediate verdict: AZN shareholders see a value-destructive deal, while BMY holders see a potential premium exit.

Space Exploration Technologies or SpaceX's (SPCX) current valuation appears attractive after shares

European stock markets closed mostly higher in Monday trading as the Stoxx Europe gained 0.4%, Germa

Also, the e-bike startup spun off from Rivian Automotive Inc., will reportedly begin delivering its first e-bikes next week, ending months of delays that pushed back its original spring launch. The Launch Edition of its $4,500 TM-B e-bike has started...

The company's stock took quite a body blow after it reported first-quarter earnings.

The firm uses AI and machine-learning models to detect signs of coercion or manipulation in digital transactions, helping banks distinguish criminal activity from legitimate ones in real time.

Bristol Myers Squibb stock is surging Monday following a report of a potential mega-merger with a competitor.

AstraZeneca stock took a nosedive Monday amid reports it's mulling a mega-merger with Bristol Myers Squibb.

A combination of the two pharmaceutical companies could create an entity valued at nearly $400 billion, according to the Financial Times